Rehmann Capital Advisory Group’s QIAGEN NV QGENF Stock Holding History

Rehmann Capital Advisory Group’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,581	Closed	-$208K	–	408
2016 Q3	$208K	Buy	+7,581	New	+$208K	0.04%	345
2016 Q1	–	Sell	-9,105	Closed	-$252K	–	407
2015 Q4	$252K	Sell	9,105 -191	-2%	-$5.29K	0.05%	270
2015 Q3	$240K	Buy	9,296 +670	+8%	+$17.3K	0.05%	268
2015 Q2	$214K	Sell	8,626 -20	-0.2%	-$496	0.05%	302
2015 Q1	$218K	Sell	8,646 -267	-3%	-$6.73K	0.05%	303
2014 Q4	$209K	Buy	+8,913	New	+$209K	0.05%	306

Other funds holding QGENF

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rehmann Capital Advisory Group's QGENF Position: Q4 2016 in Review

Rehmann Capital Advisory Group sold out of QIAGEN NV (QGENF) in Q4 2016, closing a stake of 7,581 shares — an estimated $208K sold.

Rehmann Capital Advisory Group first reported a position in QGENF in Q4 2014 and held it in 6 quarters. The position peaked at $252K in Q4 2015. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

Rehmann Capital Advisory Group reported no remaining QIAGEN NV position as of Q4 2016 after selling out during the quarter.
Rehmann Capital Advisory Group sold 7,581 QIAGEN NV shares in Q4 2016, an estimated $208K.
Rehmann Capital Advisory Group first reported a position in QIAGEN NV in Q4 2014 and held it in 6 quarters.
Rehmann Capital Advisory Group's QIAGEN NV position peaked at $252K in Q4 2015.
189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on Rehmann Capital Advisory Group's 13F filing for Q4 2016, filed 13 Feb 2017.